New research published this week reconfirms that advanced imaging utilization is on a steady decline, after having peaked in the periods immediately before and after the turn of the century. At what point are such reimbursement cuts just too much?
A recent study in the journal Health Affairs clearly illustrates the price that the U.S. pays due to the high costs associated with healthcare. With that in mind, there are steps that healthcare organizations--and the radiologists working within those organizations--can take to provide high quality, yet cost-effective services.
Last week, the USPSTF unveiled a draft research plan it will use to guide what it calls a "systematic review" of evidence on breast screening. A resulting evidence report will form a USPSTF Recommendation Statement on the subject.
The Centers for Disease Control and Prevention last week announced that colorectal cancer screening rates--after years of increases--seem to have stalled. In fact, millions of Americans between the ages of 50 and 75, it says, have never been screened. This obviously concerns public health authorities since screening has been shown to reduce death rates.
Over the past several weeks the Affordable Care Act has been at the forefront of political arguments over budgets and debt ceilings, and we should be reminded that it is a law that certainly will have a continuing impact on radiology. In fact, the shift toward different payment models demands that all radiologists will have to start proving their value.
A pair of recent studies--both published in the Journal of the American College of Radiology--seem to offer some ammunition to radiologists worried about their specialty's wider reputation and who have questions about what it is becoming. Is it in danger of becoming a commodity?
Over the last several years the radiology profession has focused much attention on declining reimbursement rates. But the fact remains that the number of job opportunities for radiologists isn't growing either.